Vesugen
🔹 What is Vesugen?
Class: Short peptide bioregulator derived from vascular tissue. Mechanism:
- Promotes regeneration of endothelial cells, supporting the elasticity and functional health of blood vessels.
- Enhances circulatory flow, helping reduce vascular resistance and inflammation along vessel walls.
- Carries anti-atherosclerotic properties, helping protect against arterial plaque buildup that contributes to hypertension and vascular disease.
Primary focus:
- Cardiovascular and circulatory health — improving blood vessel function to reduce risk factors tied to heart disease and stroke.
- Supporting oxygen and nutrient delivery to tissues via better vascular efficiency, and helping prevent complications from chronic conditions like hypertension and ischemia.
🔹 Oral Dosage (primary route) Range:
- 20 mg per capsule, typically 1–2 capsules, 1–2 times daily.
Frequency:
- Taken 15–20 minutes before meals, for a course of 30 days.
Rationale: Vesugen follows the standard oral bioregulator convention in this family — pre-meal capsule dosing over a defined course rather than continuous daily use.
🔹 Cycle Length Common cycle length: 30-day course. Off-cycle: Often used in repeated cycles to maintain long-term vascular health rather than as a single one-time intervention.
🔹 Optimal Dosing Window
- Pre-meal dosing, split across the day for the twice-daily protocol.
- Best treated as an ongoing periodic vascular-maintenance course, particularly for those tracking cardiovascular risk factors.
✅ Educational Integration Example (oral)
- Example protocol: 20 mg, 1 capsule before breakfast and dinner, for 30 days, repeated periodically as part of a broader cardiovascular maintenance approach.
- Frequently discussed alongside Ventfort, given the shared vascular-health mechanism, for a fuller circulatory-support protocol.
🔹 Stacking Strategy (Educational / Complementary) Since Vesugen targets endothelial repair and circulatory function, complementary pairings stay within the cardiovascular category: 🔸 Vascular & Circulatory Support:
- Ventfort: Overlapping vascular-wall mechanism from a different tissue source; commonly discussed as a complementary pairing rather than a duplicate.
🔸 Metabolic Support:
- Broader metabolic-health bioregulators can be layered in without redundancy, since Vesugen’s focus stays specific to vessel-wall function.
Rationale: Vesugen’s mechanism centers on the vascular endothelium, so stacking logic favors reinforcing circulatory health broadly rather than combining with unrelated organ-specific bioregulators.
Studied in Humans? Limited (primarily Russian/Eastern European research, minimal Western clinical trials)
FDA Approved? No
Allowed for 503a Compounding Pharmacy? No
Disclaimer: Do not rely on any dosing information provided, this is for educational and research only. Always double and triple check alternative references for education. Please consult with healthcare provider for your specific dosing and protocol if applicable.